A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)

NCT07500090 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

248

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Hypersomnia

Interventions

DRUG: HBS-301 tablet
DRUG: Placebo

Sponsor

Harmony Biosciences Management, Inc.